Skip to main content
Top
Published in: Inflammation 5/2013

01-10-2013

The Relationship Between N-acetylcysteine, Hyperbaric Oxygen, and Inflammation in a Rat Model of Acetaminophen-induced Nephrotoxicity

Authors: Hakan Cermik, Mine Yavuz Taslipinar, Ibrahim Aydin, Mehmet Agilli, Fevzi Nuri Aydin, Fatma Ucar, Bilal Firat Alp, Mehmet Toygar, Esin Ozkan, Ertan Altayli, Tuncer Cayci

Published in: Inflammation | Issue 5/2013

Login to get access

Abstract

An overdose of acetaminophen (APAP) produces acute tubular necrosis. The aim of this study was to observe the effects of hyperbaric oxygen (HBO) only and combined with N-acetylcysteine (NAC) on inflammatory cytokines in kidney. Thirty-two male Sprague–Dawley rats were divided into four groups: sham, control (APAP), NAC, and NAC + HBO. In the APAP, NAC, and NAC + HBO groups, renal injury was induced by oral administration of 1 g/kg APAP. The NAC group received NAC (100 mg/kg/day). NAC + HBO group received NAC (100 mg/kg/day) intraperitoneally and HBO underwent at 2.8 ATA pressure with 100 % oxygen inhalation for 90 min every 12 h for 5 days. Rats in the sham group received distilled water only by gastric tube. All animals were killed on 6 days after APAP or distilled water administration. Creatinine, urea, neopterin, tumor necrosis factor-α (TNF-α), and interleukin (IL)-6 levels were measured in sera. There was a significant increase in serum creatinine and urea levels in the control group compared to the sham group (in both, p = 0.001). NAC and NAC + HBO significantly decreased serum neopterin, TNF-α, and IL-6 levels compared to control group. APAP administration caused tubular necrosis in the renal. NAC and NAC + HBO treatments significantly reduced APAP-induced renal damage. The results of this study showed that renal dysfunction in APAP toxicity was attenuated by the use of HBO and NAC treatments. The combination of NAC and HBO treatments might be recommended as an effective treatment modality for APAP-induced nephrotoxicity.
Literature
1.
go back to reference Cakir, E., O.E. Akgul, I. Aydin, T. Cayci, Y.G. Kurt, O. Onguru, F.N. Aydin, M. Agilli, H. Yaman, N. Ersoz, S. Bilgic, A. Guven, T. Turker, C. Bilgi, and K.M. Erbil. 2010. The association between neopterin and acetaminophen-induced nephrotoxicity. Renal Failure 32: 740–746.PubMedCrossRef Cakir, E., O.E. Akgul, I. Aydin, T. Cayci, Y.G. Kurt, O. Onguru, F.N. Aydin, M. Agilli, H. Yaman, N. Ersoz, S. Bilgic, A. Guven, T. Turker, C. Bilgi, and K.M. Erbil. 2010. The association between neopterin and acetaminophen-induced nephrotoxicity. Renal Failure 32: 740–746.PubMedCrossRef
2.
go back to reference Demirbas, S., E. Cakir, E.O. Akgul, M. Seyrek, T. Cayci, Y.G. Kurt, B. Uysal, I. Aydin, B. Kurt, H. Yaman, and M.K. Erbil. 2011. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 31: 165–170.PubMedCrossRef Demirbas, S., E. Cakir, E.O. Akgul, M. Seyrek, T. Cayci, Y.G. Kurt, B. Uysal, I. Aydin, B. Kurt, H. Yaman, and M.K. Erbil. 2011. Elevated serum neopterin levels in acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 31: 165–170.PubMedCrossRef
3.
go back to reference Gul, H., B. Uysal, E. Cakir, H. Yaman, E. Macit, A.O. Yildirim, Y.E. Eyi, U. Kaldirim, E. Oztas, E.O. Akgul, T. Cayci, M. Ozler, T. Topal, S. Oter, A. Korkmaz, M. Toygar, and S. Demirbag. 2012. The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 34: 81–86.PubMedCrossRef Gul, H., B. Uysal, E. Cakir, H. Yaman, E. Macit, A.O. Yildirim, Y.E. Eyi, U. Kaldirim, E. Oztas, E.O. Akgul, T. Cayci, M. Ozler, T. Topal, S. Oter, A. Korkmaz, M. Toygar, and S. Demirbag. 2012. The protective effects of ozone therapy in a rat model of acetaminophen-induced liver injury. Environmental Toxicology and Pharmacology 34: 81–86.PubMedCrossRef
4.
go back to reference Yaman, H., S. Isbilir, E. Cakir, and B. Uysal. 2011. Current issues with paracetamol induced toxicity. Journal of Experimental and Integrative Medicine 1: 165–166.CrossRef Yaman, H., S. Isbilir, E. Cakir, and B. Uysal. 2011. Current issues with paracetamol induced toxicity. Journal of Experimental and Integrative Medicine 1: 165–166.CrossRef
5.
go back to reference Salhanick, S.D., B. Belikoff, D. Orlow, D. Holt, W. Reenstra, and J.A. Buras. 2006. Hyperbaric oxygen reduces acetaminophen toxicity and increases HIF-1alpha expression. Academic Emergency Medicine 13: 707–714.PubMedCrossRef Salhanick, S.D., B. Belikoff, D. Orlow, D. Holt, W. Reenstra, and J.A. Buras. 2006. Hyperbaric oxygen reduces acetaminophen toxicity and increases HIF-1alpha expression. Academic Emergency Medicine 13: 707–714.PubMedCrossRef
6.
go back to reference Atasoyu, E.M., S. Yildiz, M. Cimsit, H. Cermik, T. Qyrdedi, T.R. Evrenkaya, S. Aktas, G. Uzun, O. Bilgi, and M. Gultepe. 2006. Investigation of the effect of hyperbaric oxygen on experimental cyclosporine nephrotoxicity. Basic & Clinical Pharmacology & Toxicology 98: 150–154.CrossRef Atasoyu, E.M., S. Yildiz, M. Cimsit, H. Cermik, T. Qyrdedi, T.R. Evrenkaya, S. Aktas, G. Uzun, O. Bilgi, and M. Gultepe. 2006. Investigation of the effect of hyperbaric oxygen on experimental cyclosporine nephrotoxicity. Basic & Clinical Pharmacology & Toxicology 98: 150–154.CrossRef
7.
go back to reference Tibbles, P.M., and J.S. Edelsberg. 1996. Hyperbaric-oxygen therapy. The New England Journal of Medicine 334: 1642–1648.PubMedCrossRef Tibbles, P.M., and J.S. Edelsberg. 1996. Hyperbaric-oxygen therapy. The New England Journal of Medicine 334: 1642–1648.PubMedCrossRef
8.
go back to reference Atasoyu, E.M., S. Yildiz, O. Bilgi, H. Cermik, R. Evrenkaya, S. Aktas, M. Gultepe, and E.G. Kandemir. 2005. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats. Archives of Toxicology 79: 289–293.PubMedCrossRef Atasoyu, E.M., S. Yildiz, O. Bilgi, H. Cermik, R. Evrenkaya, S. Aktas, M. Gultepe, and E.G. Kandemir. 2005. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats. Archives of Toxicology 79: 289–293.PubMedCrossRef
9.
go back to reference Yasar, M., S. Yildiz, R. Mas, K. Dundar, A. Yildirim, A. Korkmaz, C. Akay, N. Kaymakcioglu, T. Ozisik, and D. Sen. 2003. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiological Research 52: 111–116.PubMed Yasar, M., S. Yildiz, R. Mas, K. Dundar, A. Yildirim, A. Korkmaz, C. Akay, N. Kaymakcioglu, T. Ozisik, and D. Sen. 2003. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiological Research 52: 111–116.PubMed
10.
go back to reference Chen, M.F., H.M. Chen, S.W. Ueng, and M.H. Shyr. 1998. Hyperbaric oxygen pretreatment attenuates hepatic reperfusion injury. Liver 18: 110–116.PubMed Chen, M.F., H.M. Chen, S.W. Ueng, and M.H. Shyr. 1998. Hyperbaric oxygen pretreatment attenuates hepatic reperfusion injury. Liver 18: 110–116.PubMed
11.
go back to reference Edremitlioglu, M., D. Kilic, S. Oter, U. Kisa, A. Korkmaz, O. Coskun, and O. Bedir. 2005. The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage. Surgery Today 35: 653–661.PubMedCrossRef Edremitlioglu, M., D. Kilic, S. Oter, U. Kisa, A. Korkmaz, O. Coskun, and O. Bedir. 2005. The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage. Surgery Today 35: 653–661.PubMedCrossRef
12.
go back to reference Yeh, C.H., Z.C. Chen, C.C. Hsu, M.T. Lin, and C.C. Chen. 2010. Protection in rats with heatstroke: hyperbaric oxygen vs activated protein C therapy. European Journal of Pharmacology 635: 103–108.PubMedCrossRef Yeh, C.H., Z.C. Chen, C.C. Hsu, M.T. Lin, and C.C. Chen. 2010. Protection in rats with heatstroke: hyperbaric oxygen vs activated protein C therapy. European Journal of Pharmacology 635: 103–108.PubMedCrossRef
13.
go back to reference Al-Waili, N.S., G.J. Butler, B.Y. Lee, Z. Carrey, and R. Petrillo. 2009. Possible application of hyperbaric oxygen technology in the management of urogenital and renal diseases. Journal of Medical Engineering & Technology 33: 507–515.CrossRef Al-Waili, N.S., G.J. Butler, B.Y. Lee, Z. Carrey, and R. Petrillo. 2009. Possible application of hyperbaric oxygen technology in the management of urogenital and renal diseases. Journal of Medical Engineering & Technology 33: 507–515.CrossRef
14.
go back to reference Al-Waili, N.S., and G.J. Butler. 2006. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. The Scientific World Journal 6: 425–441.CrossRef Al-Waili, N.S., and G.J. Butler. 2006. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. The Scientific World Journal 6: 425–441.CrossRef
15.
go back to reference Rinaldi, B., S. Cuzzocrea, M. Donniacuo, A. Capuano, D. Di Palma, F. Imperatore, E. Mazzon, R. Di Paola, L. Sodano, and F. Rossi. 2011. Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures. Intensive Care Medicine 37: 1110–1119.PubMedCrossRef Rinaldi, B., S. Cuzzocrea, M. Donniacuo, A. Capuano, D. Di Palma, F. Imperatore, E. Mazzon, R. Di Paola, L. Sodano, and F. Rossi. 2011. Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures. Intensive Care Medicine 37: 1110–1119.PubMedCrossRef
16.
go back to reference Jain, K.K. 2004. Drug interactions with hyperbaric oxygen. In Textbook of hyperbaric oxygen, ed. K.K. Jain, 80–82. Cambridge: Hogrefe-Huber Publishers. Jain, K.K. 2004. Drug interactions with hyperbaric oxygen. In Textbook of hyperbaric oxygen, ed. K.K. Jain, 80–82. Cambridge: Hogrefe-Huber Publishers.
17.
go back to reference Caglikulekci, M., C. Pata, D.D. Apa, M. Dirlik, L. Tamer, F. Yaylak, A. Kanik, and S. Aydin. 2004. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharmacological Research 49: 227–238.PubMedCrossRef Caglikulekci, M., C. Pata, D.D. Apa, M. Dirlik, L. Tamer, F. Yaylak, A. Kanik, and S. Aydin. 2004. The effect of N-acetylcysteine (NAC) on liver and renal tissue inducible nitric oxide synthase (iNOS) and tissue lipid peroxidation in obstructive jaundice stimulated by lipopolysaccharide (LPS). Pharmacological Research 49: 227–238.PubMedCrossRef
18.
go back to reference Hsu, B.G., R.P. Lee, F.L. Yang, H.J. Harn, and H.I. Chen. 2006. Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sciences 79: 2010–2016.PubMedCrossRef Hsu, B.G., R.P. Lee, F.L. Yang, H.J. Harn, and H.I. Chen. 2006. Post-treatment with N-acetylcysteine ameliorates endotoxin shock-induced organ damage in conscious rats. Life Sciences 79: 2010–2016.PubMedCrossRef
19.
go back to reference Hsu, B.G., F.L. Yang, R.P. Lee, T.C. Peng, H.J. Harn, and H.I. Chen. 2004. N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. Journal of Biomedical Science 11: 152–162.PubMedCrossRef Hsu, B.G., F.L. Yang, R.P. Lee, T.C. Peng, H.J. Harn, and H.I. Chen. 2004. N-acetylcysteine ameliorates lipopolysaccharide-induced organ damage in conscious rats. Journal of Biomedical Science 11: 152–162.PubMedCrossRef
20.
go back to reference Altinel, O., S. Demirbas, E. Cakir, H. Yaman, I.H. Ozerhan, E. Duran, T. Cayci, E.O. Akgul, N. Ersoz, B. Uysal, B. Kurt, M. Yasar, S. Oter, and Y. Peker. 2011. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scandinavian Journal of Clinical and Laboratory Investigation 71: 185–192.PubMedCrossRef Altinel, O., S. Demirbas, E. Cakir, H. Yaman, I.H. Ozerhan, E. Duran, T. Cayci, E.O. Akgul, N. Ersoz, B. Uysal, B. Kurt, M. Yasar, S. Oter, and Y. Peker. 2011. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scandinavian Journal of Clinical and Laboratory Investigation 71: 185–192.PubMedCrossRef
21.
go back to reference Yaman, H., E. Cakir, O. Ozcan, Z. Yesilova, A. Ozcan, E.O. Akgul, M.K. Erbil, S. Bagci, C. Bilgi, and K. Dagalp. 2005. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clinical Biochemistry 38: 187–190.PubMedCrossRef Yaman, H., E. Cakir, O. Ozcan, Z. Yesilova, A. Ozcan, E.O. Akgul, M.K. Erbil, S. Bagci, C. Bilgi, and K. Dagalp. 2005. Elevated urine neopterin levels in nonalcoholic steatohepatitis. Clinical Biochemistry 38: 187–190.PubMedCrossRef
22.
go back to reference Agilli, M., H. Yaman, T. Cayci, I. Sener, M. Oztosun, I. Aydin, F.N. Aydin, Y.G. Kurt, E. Cakir, and E.O. Akgul. 2012. Comparison of two different HPLC methods and Elisa method for measurement of serum neopterin. Journal of Investigational Biochemistry 1: 43–47.CrossRef Agilli, M., H. Yaman, T. Cayci, I. Sener, M. Oztosun, I. Aydin, F.N. Aydin, Y.G. Kurt, E. Cakir, and E.O. Akgul. 2012. Comparison of two different HPLC methods and Elisa method for measurement of serum neopterin. Journal of Investigational Biochemistry 1: 43–47.CrossRef
23.
go back to reference Yamanel, L., U. Kaldirim, Y. Oztas, O. Coskun, Y. Poyrazoglu, M. Durusu, T. Cayci, A. Ozturk, S. Demirbas, M. Yasar, O. Cinar, S.K. Tuncer, Y.E. Eyi, B. Uysal, T. Topal, S. Oter, and A. Korkmaz. 2011. Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. International Journal of Medical Sciences 8: 48–55.PubMedCrossRef Yamanel, L., U. Kaldirim, Y. Oztas, O. Coskun, Y. Poyrazoglu, M. Durusu, T. Cayci, A. Ozturk, S. Demirbas, M. Yasar, O. Cinar, S.K. Tuncer, Y.E. Eyi, B. Uysal, T. Topal, S. Oter, and A. Korkmaz. 2011. Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. International Journal of Medical Sciences 8: 48–55.PubMedCrossRef
24.
go back to reference van der Poll, T., and S.J. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infectious Disease Clinics of North America 13: 413–426.PubMedCrossRef van der Poll, T., and S.J. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infectious Disease Clinics of North America 13: 413–426.PubMedCrossRef
25.
go back to reference Ruokonen, E., L. Ilkka, M. Niskanen, and J. Takala. 2002. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiologica Scandinavica 46: 398–404.PubMedCrossRef Ruokonen, E., L. Ilkka, M. Niskanen, and J. Takala. 2002. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiologica Scandinavica 46: 398–404.PubMedCrossRef
26.
go back to reference Weisz, G., A. Lavy, Y. Adir, Y. Melamed, D. Rubin, S. Eidelman, and S. Pollack. 1997. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn’s disease. Journal of Clinical Immunology 17: 154–159.PubMedCrossRef Weisz, G., A. Lavy, Y. Adir, Y. Melamed, D. Rubin, S. Eidelman, and S. Pollack. 1997. Modification of in vivo and in vitro TNF-alpha, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn’s disease. Journal of Clinical Immunology 17: 154–159.PubMedCrossRef
27.
go back to reference Nandi, J., B. Saud, J.M. Zinkievich, Z.J. Yang, and R.A. Levine. 2010. TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. Molecular and Cellular Biochemistry 336: 17–24.PubMedCrossRef Nandi, J., B. Saud, J.M. Zinkievich, Z.J. Yang, and R.A. Levine. 2010. TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. Molecular and Cellular Biochemistry 336: 17–24.PubMedCrossRef
28.
go back to reference Lahat, N., H. Bitterman, N. Yaniv, A. Kinarty, and N. Bitterman. 1995. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clinical and Experimental Immunology 102: 655–659.PubMedCrossRef Lahat, N., H. Bitterman, N. Yaniv, A. Kinarty, and N. Bitterman. 1995. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-alpha) secretion from rat macrophages. Clinical and Experimental Immunology 102: 655–659.PubMedCrossRef
29.
go back to reference Benson, R.M., L.M. Minter, B.A. Osborne, and E.V. Granowitz. 2003. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clinical and Experimental Immunology 134: 57–62.PubMedCrossRef Benson, R.M., L.M. Minter, B.A. Osborne, and E.V. Granowitz. 2003. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clinical and Experimental Immunology 134: 57–62.PubMedCrossRef
30.
go back to reference Pan, H.C., C.S. Chin, D.Y. Yang, S.P. Ho, C.J. Chen, S.M. Hwang, M.H. Chang, and F.C. Cheng. 2009. Human amniotic fluid mesenchymal stem cells in combination with hyperbaric oxygen augment peripheral nerve regeneration. Neurochemical Research 34: 1304–1316.PubMedCrossRef Pan, H.C., C.S. Chin, D.Y. Yang, S.P. Ho, C.J. Chen, S.M. Hwang, M.H. Chang, and F.C. Cheng. 2009. Human amniotic fluid mesenchymal stem cells in combination with hyperbaric oxygen augment peripheral nerve regeneration. Neurochemical Research 34: 1304–1316.PubMedCrossRef
31.
go back to reference Granowitz, E.V., E.J. Skulsky, R.M. Benson, J. Wright, J.L. Garb, E.R. Cohen, E.C. Smithline, and R.B. Brown. 2002. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea & Hyperbaric Medicine 29: 216–225. Granowitz, E.V., E.J. Skulsky, R.M. Benson, J. Wright, J.L. Garb, E.R. Cohen, E.C. Smithline, and R.B. Brown. 2002. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea & Hyperbaric Medicine 29: 216–225.
32.
go back to reference Choudhury, D., and M. Levi. 2011. Kidney aging—inevitable or preventable? Nature Reviews Nephrology 7: 706–717.PubMedCrossRef Choudhury, D., and M. Levi. 2011. Kidney aging—inevitable or preventable? Nature Reviews Nephrology 7: 706–717.PubMedCrossRef
33.
go back to reference Spapen, H., H. Zhang, C. Demanet, W. Vleminckx, J.L. Vincent, and L. Huyghens. 1998. Does N-acetyl-l-cysteine influence cytokine response during early human septic shock? Chest 113: 1616–1624.PubMedCrossRef Spapen, H., H. Zhang, C. Demanet, W. Vleminckx, J.L. Vincent, and L. Huyghens. 1998. Does N-acetyl-l-cysteine influence cytokine response during early human septic shock? Chest 113: 1616–1624.PubMedCrossRef
34.
go back to reference Zafarullah, M., W.Q. Li, J. Sylvester, and M. Ahmad. 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences 60: 6–20.PubMedCrossRef Zafarullah, M., W.Q. Li, J. Sylvester, and M. Ahmad. 2003. Molecular mechanisms of N-acetylcysteine actions. Cellular and Molecular Life Sciences 60: 6–20.PubMedCrossRef
35.
go back to reference Luo, J., T. Tsuji, H. Yasuda, Y. Sun, Y. Fujigaki, and A. Hishida. 2008. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrology, Dialysis, Transplantation 23: 2198–2205.PubMedCrossRef Luo, J., T. Tsuji, H. Yasuda, Y. Sun, Y. Fujigaki, and A. Hishida. 2008. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrology, Dialysis, Transplantation 23: 2198–2205.PubMedCrossRef
36.
go back to reference Mishima, K., A. Baba, M. Matsuo, Y. Itoh, and R. Oishi. 2006. Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radical Biology & Medicine 40: 1564–1577.CrossRef Mishima, K., A. Baba, M. Matsuo, Y. Itoh, and R. Oishi. 2006. Protective effect of cyclic AMP against cisplatin-induced nephrotoxicity. Free Radical Biology & Medicine 40: 1564–1577.CrossRef
37.
go back to reference Shalby, A.B., N. Assaf, and H.H. Ahmed. 2011. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats. Toxicology Mechanisms and Methods 21: 538–546.PubMedCrossRef Shalby, A.B., N. Assaf, and H.H. Ahmed. 2011. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats. Toxicology Mechanisms and Methods 21: 538–546.PubMedCrossRef
38.
go back to reference Abdel-Zaher, A.O., R.H. Abdel-Hady, M.M. Mahmoud, and M.M. Farrag. 2008. The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. Toxicology 243: 261–270.PubMedCrossRef Abdel-Zaher, A.O., R.H. Abdel-Hady, M.M. Mahmoud, and M.M. Farrag. 2008. The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. Toxicology 243: 261–270.PubMedCrossRef
39.
go back to reference Abraham, P. 2005. Vitamin C may be beneficial in the prevention of paracetamol-induced renal damage. Clinical and Experimental Nephrology 9: 24–30.PubMedCrossRef Abraham, P. 2005. Vitamin C may be beneficial in the prevention of paracetamol-induced renal damage. Clinical and Experimental Nephrology 9: 24–30.PubMedCrossRef
Metadata
Title
The Relationship Between N-acetylcysteine, Hyperbaric Oxygen, and Inflammation in a Rat Model of Acetaminophen-induced Nephrotoxicity
Authors
Hakan Cermik
Mine Yavuz Taslipinar
Ibrahim Aydin
Mehmet Agilli
Fevzi Nuri Aydin
Fatma Ucar
Bilal Firat Alp
Mehmet Toygar
Esin Ozkan
Ertan Altayli
Tuncer Cayci
Publication date
01-10-2013
Publisher
Springer US
Published in
Inflammation / Issue 5/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9649-4

Other articles of this Issue 5/2013

Inflammation 5/2013 Go to the issue